Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kawazoe A, Yamaguchi K, Yasui H, Negoro Y, et al. Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study. Eur J Cancer 2020;129:97-106.
PMID: 32145474

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016